All is well. This company is transitioning into a revenue-generating machine. Per the Q&A, the company is focusing its immediate funding efforts on the compounding pharmacy, PIMD, and WRx businesses. The potential with these is significant. We are in the early period of the product registration approval process in China, approval no later than 1/30. The ship is turning...do not be scared out of your shares. Instead, I recommend that all the longs here go back, re-read your DD, look at what the company as done since 9/30/13, and add on these dips. Ironridge is selling. Let's take advantage of this fore sale, lower our average basis, and buy up more of the float. I'm not selling here.
Team BSAV is over 5M shares, and I know Teams Cwell, Kansai, TutGuts and others are at about 15M and continuing to accumulate.
Scrips is the read deal. The more fear, the better time to buy.
Good luck to all the longs!
BSAV
News 
Market Data 
Discover 
AI
